Orphic Therapeutics Information

Orphic Therapeutics identifies and acquires underperforming biopharmaceutical therapies that are currently indicated for chronic orphan diseases. These specific drugs, though proven effective, are presently underutilized or no longer distributed. Orphic's business model works to repurpose these therapies and make them available to benefit the small patient populations which rely on their long-term therapeutic efficacy. With a patient-driven mission of, "Advancing proven therapies until there is a cure," Orphic Therapeutics fulfills the specialized requirements of serving patients, providers and the orphan drug community. To learn more, visit orphictherapeutics.com